ENDRA Life Sciences financials at a glance

+ Portfolio

The revenue of ENDRA Life Sciences is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -1.58 Dollars per share in 2023, which was 20 higher than 2021. And about -0.00965 billion Dollars are reported as free cash flow in the financials of ENDRA Life Sciences 2023. No dividends were paid to the shareholders of the ENDRA Life Sciences stock NasdaqCM:NDRA in the financial year 2023.

$0.00M

Revenue

$-4.56

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-4.56

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.01M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	100.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-2.37	$-4.56	$-5.70	$-12.60	$-46.80	$-42.22
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0
Sha.	Shares	N/AM	3.17M	2.2M	2.08M	0.67M	0.37M
OCF	Operating Cash Flow	N/A	$-12.77M	$-11.13M	$0.00M	$-8.59M	$0.00M
FCF	Free Cash Flow	N/A	$-12.97M	$-11.18M	$0.00M	$-8.63M	$0.00M
FCFS	Free Cash Flow Per Share	$-2.10	$-4.49	$-0.27	$-0.56	$-1.15	$-1.73

ENDRA Life Sciences financials at a glance

Financials

Discover